Dianthus Therapeutics
DNTH
DNTH
92 hedge funds and large institutions have $255M invested in Dianthus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
35
Reduced
25
Closed
8
Calls
$46K
Puts
$164K
Net Calls
-$118K
Net Calls Change
-$32K
Top Buyers
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$7.84M |
| 2 |
Renaissance Technologies
New York
|
$1.68M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
$985K |
| 4 |
Squarepoint
New York
|
$110K |
| 5 |
UBS AM
Chicago,
Illinois
|
$4.37M |
